Occuity
Occuity is a private UK medical technology company that designs non-contact optical instruments for healthcare screening. Using light-based eye measurement technology, the company enables direct ophthalmic assessments and detection of systemic conditions including diabetes and Alzheimer's Disease.
- Company typePrivate
- Founded2019
- HeadquartersReading, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Occuity does
Occuity Ltd is a private medical technology company founded in 2019 and headquartered in Reading, United Kingdom, that specializes in the research, design, and production of handheld non-contact optical instruments for healthcare screening and monitoring. The company's core technology is based on shining light into the eye and analyzing the return signal, which enables direct ophthalmic measurements for optometrists and ophthalmologists as well as detection and monitoring of broader systemic health conditions such as diabetes and Alzheimer's Disease. This positions Occuity at the intersection of ophthalmology and systemic disease diagnostics.
Occuity's product portfolio includes the PM1 Pachymeter (a non-contact handheld instrument for corneal thickness measurement used in glaucoma screening), the AX1 Axial Length Biometer (for myopia management), and the Occuity Indigo (a non-invasive glucose monitor in development). The company operates a hybrid go-to-market model combining direct website sales with a global distributor-led network spanning close to 20 regions, supported by crowdfunding platforms including Seedrs, Republic, and Crowdcube for retail investor engagement and capital raising.
As of the available data, Occuity has 11-50 employees, indicating an early-to-mid stage growth company. The company has raised approximately £10.5 million cumulatively (£9 million from angel investors plus approximately £1.5 million via crowdfunding), with a current crowdfunding round on Republic that has already raised £3M+ against a £2M target. The PM1 Pachymeter has received CE marking, enabling commercial sales in UK and European markets, while other products are in active development or regulatory approval processes targeting 2026 launches.
Occuity firmographics
Firmographics- Name
- Occuity
- Legal name
- Occuity Ltd.
- Website
- https://occuity.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Occuity is a private UK medical technology company that designs non-contact optical instruments for healthcare screening. Using light-based eye measurement technology, the company enables direct ophthalmic assessments and detection of systemic conditions including diabetes and Alzheimer's Disease.
- Ownership category
- akta.pro rank
Occuity industry classification
Industry- Product category
- Ophthalmic and Optical Medical Devices
- NAICS
- Ophthalmic Goods Manufacturing (339115)
- SIC
- Ophthalmic Goods (3851), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)
Keywords
Where Occuity is headquartered
LocationHeadquarters
- HQ city
- Reading
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Occuity business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Medical Device Sales: Direct sales of PM1 Pachymeter and AX1 Axiometer devices. PM1 is already commercially available and selling globally through distributor network. AX1 launching in 2026 with strong pre-orders. Pricing around $10,000 per device for AX1.
- Device-as-a-Service (Future): Longer-term model for Oculomics devices (diabetes screening, glucose monitoring) planned as device-as-a-service with monthly recurring revenue. Retaining ownership and control of data generated, with AI and neural networks applied to datasets for enhanced clinical value.
- Crowdfunding/Investment Rounds: Republic crowdfunding round targeting £2 million. Historical rounds via Seedrs and Crowdcube. Angel investor participation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | AX1 Axiometer - Ophthalmic Device |
| Other | One time/ perpetual license | Republic Crowdfunding Investment |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
Occuity product offering
Product offeringCore offering
Occuity designs, develops and manufactures handheld, non-contact optical medical devices that shine light into the eye and analyse the return signal to make measurements. Its commercial products are the PM1 Pachymeter (for corneal thickness measurement in glaucoma screening) and the AX1 Axiometer (for axial length measurement in myopia management), with the Occuity Indigo non-invasive glucose monitor and SD1 diabetes screening device in development as part of the broader Oculomics platform for systemic disease detection through the eye.
Product overview
Occuity offers a platform of handheld, non-contact optical medical devices for healthcare screening and monitoring. The core products include the PM1 Pachymeter (commercially available for corneal thickness measurement in glaucoma care), the AX1 Axiometer (for axial length measurement in myopia management), and the Occuity Indigo (non-invasive glucose monitor in development). The company is also developing the SD1 diabetes screening device. All devices share a common optical platform technology that analyzes light reflected from the eye to make measurements without touching the patient. The PM1 is CE marked and commercially available, while the AX1 is in regulatory approval for 2026 launch and Indigo represents the company's long-term vision for non-invasive chronic disease monitoring through the eye.
Differentiator
Problem solved
Functional benefit
Brands
- PM1 Pachymeter: World's first handheld, non-contact optical pachymeter for measuring corneal thickness in glaucoma screening.
- AX1 Axiometer
- Occuity Indigo
- Oculomics
Products and services
- PM1 Pachymeter The world's first handheld, non-contact optical pachymeter that measures corneal thickness for glaucoma screening and refractive surgery planning. Uses optical confocal scanning technology, requires no eye contact, probes, anaesthetic drops or consumables, and is sold to ophthalmologists, optometrists and eye hospitals.
- AX1 Axiometer Handheld, non-contact optical biometer that measures axial length of the eye for myopia management in children and adults. Designed as a fast, portable alternative to traditional desktop axial length biometers, with a quick learning curve and the ability to be used in school and community screening settings.
- Occuity Indigo Non-invasive glucose monitor in development that measures blood glucose through the eye using confocal scanning and refractive index analysis, intended to eliminate finger-prick tests and invasive continuous glucose monitors for diabetes patients.
- SD1 Diabetes Screening Device Prototype device that detects Advanced Glycation End-products (AGEs) in the eye for diabetes screening, built on the same optical platform as PM1 and AX1 to provide accurate, non-invasive assessments of diabetes risk and progression.
Quantifiable outcome
- Reduced measurement failures: Lenstar failed 10/318 eyes vs PM1 only 5/318 in school study
- +1 more outcomes
Companies that use Occuity
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles2 records
Occuity technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Occuity partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered minor and core.
- Oxford University Innovation SuzhouminorHosted Sino-UK FIT Programme 2026 visit to China's Yangtze River Delta region. Five UK medtech SMEs participated in programme exploring collaboration opportunities with companies, regulatory experts, distributors, and investors.
- RenishawcoreRenishaw provides precision encoder technology (ATOM DX optical encoder) used within Occuity's optical platform for high-precision positional measurement in PM1 Pachymeter and AX1 Axiometer products. Case study published highlighting partnership.
- Boehringer IngelheimcoreSynapse Acceleration® startup program for veterinary glucose monitoring. Developing non-invasive glucose monitoring technology for diabetic pets (dogs and cats). Project complementary to human glucose monitoring work with fewer regulatory hurdles.
- Moorfields Eye HospitalcoreWorld-renowned eye hospital conducting clinical trials for PM1 Pachymeter and using AX1 Axiometer in groundbreaking school eye study screening approximately 2,500 children. Professor Anthony Khawaja evaluating PM1 in glaucoma clinics.
- CooperVisioncoreMajor ophthalmic manufacturer with letter of intent for 5,000-10,000 AX1 Axiometer units per year at approximately $10,000 per device, representing significant commercial commitment.
- Birmingham OpticalcoreUK distributor for PM1 Pachymeter. Partnership for 100% Optical exhibitions including AX1 Speed Scan Challenge with cashback prizes of £1,000.
- Aston University (Prof. Nicola Logan)minorProfessor of Optometry & Physiological Optics participating in UKRI-funded Mynamics Project testing AX1 Axiometer for childhood myopia research in primary school settings.
- City, University of LondonminorClinical trials partner for PM1 Pachymeter alongside Moorfields Eye Hospital for regulatory approval and validation.
- Royal Berkshire HospitalminorInitial clinical investigations for glucose monitoring technology conducted with volunteers with Type 2 diabetes.
- University of ReadingminorClinical research partner for diabetes studies including Type 1 and Type 2 diabetes volunteer measurements comparing eye-based readings with blood samples.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Occuity competitors and assessment
Company assessmentDirect peers
- Reichert Technologies: Long-established US manufacturer of ophthalmic instruments including pachymeters and tonometers, with deep optometry and ophthalmology distribution. Directly comparable to Occuity's PM1 Pachymeter on product category and customer base, but lacks the handheld, non-contact differentiator.
- iCare (Revenio Group): Finnish company whose iCare tonometers and pachymeters pioneered non-contact, handheld eye measurement in primary care. Closely comparable to Occuity's handheld, non-contact positioning and overlapping glaucoma-screening use case, validating the non-contact device category.
- Carl Zeiss Meditec: Market-leading ophthalmic device company whose IOLMaster is the gold standard in optical biometry for cataract and refractive surgery. Comparable to Occuity's AX1 in axial-length measurement and shares glaucoma/cataract clinical channels, though its IOLMaster is a high-end desktop system.
- Nidek: Japanese manufacturer of a comprehensive ophthalmic device portfolio including optical biometers and pachymeters. Directly comparable to Occuity across both PM1 (pachymetry) and AX1 (biometry) product lines, with established global distribution competing for the same clinics.
- TOMEY Corporation: Japanese ophthalmic device maker with a strong portfolio in optical biometry, pachymetry, and topography. Directly comparable to Occuity across both flagship products, with established global distributor relationships that overlap Occuity's channel strategy.
- Heidelberg Engineering: German specialist in ophthalmic diagnostic imaging and measurement devices (OCT, perimetry). Comparable to Occuity as a high-precision ophthalmic diagnostic device company serving the same specialist eye-care clinical audience with premium positioning.
- Haag-Streit: Swiss ophthalmic device manufacturer whose Lenstar optical biometer is the dominant axial-length measurement device in myopia management and cataract pre-op. Directly comparable to Occuity's AX1 Axiometer on clinical use case, and competes head-to-head in the school myopia study context.
- Topcon Healthcare: Global ophthalmic diagnostic device company with optical biometers (Aladdin), pachymeters, and multimodal imaging systems. Comparable to Occuity in target customer (optometrists/ophthalmologists) and product category, particularly for myopia management and glaucoma screening workflows.
- Quantel Medical: French ophthalmic ultrasound and biometry specialist offering pachymeters and A-scan biometers. Directly comparable to Occuity on product category (corneal thickness, axial length measurement) and clinical use cases in glaucoma and cataract workflows.
Emerging players
- Cylite: Australian developer of next-generation optical biometry technology for ophthalmology. Comparable to Occuity's AX1 on use case and emerging-stage profile, but pursuing a desktop hyper-parallel OCT approach versus Occuity's handheld non-contact platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Occuity social profiles
Digital presenceOccuity compliance and trust
Trust signalCompliance1 record
Occuity financial estimates
Financial estimateRevenue estimate
Valuation estimate
Occuity leadership team
Management profileNumber of profiles
Profiles5 records
Occuity funding detail
Funding detailFunding overview
Funding rounds6 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Occuity M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Occuity
What does Occuity do?
Occuity designs, develops and manufactures handheld, non-contact optical medical devices that shine light into the eye and analyse the return signal to make measurements. Its commercial products are the PM1 Pachymeter (for corneal thickness measurement in glaucoma screening) and the AX1 Axiometer (for axial length measurement in myopia management), with the Occuity Indigo non-invasive glucose monitor and SD1 diabetes screening device in development as part of the broader Oculomics platform for systemic disease detection through the eye.
Is Occuity a public or private company?
Occuity is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Occuity founded?
Occuity was founded in 2019. It employs 11 to 50 people.
Where is Occuity based?
Occuity is headquartered in Reading, United Kingdom, in the Europe region.
How does Occuity make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are device-as-a-Service (Future) and crowdfunding/Investment Rounds.
Who are Occuity's main competitors?
Direct peers on record are Reichert Technologies, iCare (Revenio Group), Carl Zeiss Meditec, Nidek, TOMEY Corporation, Heidelberg Engineering, Haag-Streit, Topcon Healthcare and Quantel Medical. Cylite is listed as an emerging player.
Does Occuity have an API?
No public API is recorded for Occuity.
What industry is Occuity in?
Occuity's product category is Ophthalmic and Optical Medical Devices. Its primary akta.pro industry code is HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity). Its NAICS code is 339115 and its SIC code is 3851.